Gene: RABL3
Official Full Name: RAB, member of RAS oncogene family like 3provided by HGNC
Gene Summary: Predicted to enable GTP binding activity; GTPase activity; and protein homodimerization activity. Involved in regulation of Ras protein signal transduction and regulation of protein lipidation. Predicted to be active in endomembrane system. Implicated in pancreatic cancer. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20492 | RABL3 Knockout cell line (HeLa) | Human | RABL3 | 1:3~1:6 | Negative | Online Inquiry |
KO20493 | RABL3 Knockout cell line (HCT 116) | Human | RABL3 | 1:2~1:4 | Negative | Online Inquiry |
KO20494 | RABL3 Knockout cell line (HEK293) | Human | RABL3 | 1:3~1:6 | Negative | Online Inquiry |
KO20495 | RABL3 Knockout cell line (A549) | Human | RABL3 | 1:3~1:4 | Negative | Online Inquiry |
RABL3 Gene Knockout Cell Lines are specialized cell lines engineered to lack the RABL3 gene, a critical component of cellular signaling pathways involved in various developmental and disease processes. These knockouts are generated using advanced CRISPR-Cas9 technology to achieve precise gene editing, enabling researchers to study the effects of RABL3 absence in cellular models. RABL3 encodes a protein associated with rab GTPase activity, which plays significant roles in cellular trafficking and signaling, making its study vital for understanding cell proliferation, differentiation, and migration.
The primary function of RABL3 Gene Knockout Cell Lines lies in their ability to facilitate detailed investigations of the RABL3 gene’s influence on cellular functions. By eliminating RABL3, researchers can observe resulting phenotypic changes, allowing for a deeper understanding of its involvement in oncogenic processes and potential therapeutic targets. These cell lines serve as a powerful tool in both basic and applied research, particularly in cancer biology, developmental biology, and drug discovery.
The scientific importance of these cell lines extends to clinical research applications, especially in understanding tumorigenesis and evaluating the efficacy of novel therapeutic agents designed to modulate RABL3 signaling pathways. In contrast to other gene knockout models, RABL3 Gene Knockout Cell Lines offer a targeted approach with high specificity, minimizing off-target effects and enhancing the reliability of experimental outcomes.
The unique selling points of RABL3 Gene Knockout Cell Lines include their reproducibility, user-friendly application, and compatibility with a wide array of assay formats. These features not only enhance the efficiency of research workflows but also foster innovation in experimental design.
For researchers and clinicians who are focusing on cellular mechanisms and the intricate roles of genes like RABL3 in health and disease, these knockout cell lines represent an invaluable resource. They provide clarity in pathways that are often difficult to dissect, enabling discoveries that could lead to breakthroughs in understanding complex biological systems.
Our company specializes in producing high-quality biological products tailored for cutting-edge research, ensuring that our offerings are backed by rigorous testing and validation. We are committed to supporting the scientific community with innovative solutions that advance research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.